$1.25
0.00% day before yesterday
Nasdaq, Aug 30, 01:28 am CET
ISIN
IL0011050551
Symbol
EVGN

Evogene Ltd Stock price

$1.25
+0.00 0.00% 1M
-0.21 14.38% 6M
-0.62 33.16% YTD
-2.12 62.91% 1Y
-10.65 89.50% 3Y
-19.45 93.96% 5Y
-83.95 98.53% 10Y
-25.75 95.37% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.04 3.33%
ISIN
IL0011050551
Symbol
EVGN
Industry

Key metrics

Basic
Market capitalization
$10.9m
Enterprise Value
$14.0m
Net debt
$3.1m
Cash
$9.9m
Shares outstanding
6.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.6 | 1.9
EV/Sales
2.1 | 2.4
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-3.6%
Return on Equity
1,136.1%
ROCE
-120.0%
ROIC
-104.3%
Debt/Equity
-3.6
Financials (TTM | estimate)
Revenue
$6.8m | $5.8m
EBITDA
$-20.0m | $-14.7m
EBIT
$-22.4m | $-19.1m
Net Income
$-15.2m | $-15.0m
Free Cash Flow
$-21.4m
Growth (TTM | estimate)
Revenue
-26.3% | -31.5%
EBITDA
3.0% | 23.3%
EBIT
3.6% | 11.9%
Net Income
29.1% | 8.8%
Free Cash Flow
-4.6%
Margin (TTM | estimate)
Gross
41.1%
EBITDA
-296.1% | -253.0%
EBIT
-331.7%
Net
-224.8% | -258.0%
Free Cash Flow
-316.0%
More
EPS
$-2.2
FCF per Share
$-3.2
Short interest
1.8%
Employees
117
Rev per Employee
$70.0k
Show more

Is Evogene Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Evogene Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Evogene Ltd forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Evogene Ltd forecast:

Buy
88%
Hold
13%

Financial data from Evogene Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
6.77 6.77
26% 26%
100%
- Direct Costs 3.99 3.99
138% 138%
59%
2.78 2.78
63% 63%
41%
- Selling and Administrative Expenses 10 10
1% 1%
150%
- Research and Development Expense 15 15
28% 28%
222%
-20 -20
3% 3%
-296%
- Depreciation and Amortization 2.41 2.41
9% 9%
36%
EBIT (Operating Income) EBIT -22 -22
4% 4%
-331%
Net Profit -15 -15
29% 29%
-225%

In millions USD.

Don't miss a Thing! We will send you all news about Evogene Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evogene Ltd Stock News

Neutral
PRNewsWire
4 days ago
REHOVOT, Israel , Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President and CEO, will present at the H.C.
Neutral
Seeking Alpha
13 days ago
Evogene Ltd. (NASDAQ:EVGN ) Q2 2025 Earnings Conference Call August 19, 2025 9:00 AM ET Company Participants Ofer Haviv - CEO, President & Director Yaron Eldad - Chief Financial Officer Unidentified Company Representative Welcome to Evogene's Second Quarter 2025 Results Conference Call.
Neutral
PRNewsWire
13 days ago
Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a subsidiary of Evogene and the MicroBoost AI for Ag operations, are presented as a single-line item in Evogene's consolidated statements of profit and loss for the first half of 2025. Their results are included under the line titled - "Loss from o...
More Evogene Ltd News

Company Profile

Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities. The company was founded by Amir Barzilay and Hagai Karchi in 2002 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Ofer Haviv
Employees 117
Founded 1999
Website evogene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today